/

Workspace

Research & Review

Writing & Publishing

Data & Analysis

Utilities

Account

User Settings

T

Thomas Gießmann

Boehringer Ingelheim (Germany)(DE)

Claim or correct this author profile

Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.

39

Papers

2.2K

Citations

21

h-index

24

i10-index

Thomas Gießmann is an academic researcher from Boehringer Ingelheim (Germany). The author has contributed to research in topics: Drug Transport and Resistance Mechanisms & Pharmacogenetics and Drug Metabolism & Pharmacological Effects and Toxicity Studies. The author has an h-index of 21, co-authored 34 publications.

Research Topics

Drug Transport and Resistance Mechanisms Pharmacogenetics and Drug Metabolism Pharmacological Effects and Toxicity Studies Thyroid Disorders and Treatments Gastrointestinal motility and disorders

Papers by this author

works

Intestinal expression of P-glycoprotein (ABCB1), multidrug resistance associated protein 2 (ABCC2), and uridine diphosphate–glucuronosyltransferase 1A1 predicts the disposition and modulates the effects of the cholesterol absorption inhibitor ezetimibe in humans

2006 · Clinical Pharmacology & Therapeutics · 104 citations

https://doi.org/10.1016/j.clpt.2005.11.004

Stefan Oswald Sierk Haenisch Christiane Fricke Thomas Sudhop

Disposition of ezetimibe is influenced by polymorphisms of the hepatic uptake carrier OATP1B1

2008 · Pharmacogenetics and Genomics · 99 citations

https://doi.org/10.1097/fpc.0b013e3282fe9a2c

Stefan Oswald Jörg König Dieter Lütjohann Thomas Gießmann

Pharmacokinetic Evaluation of a Drug Transporter Cocktail Consisting of Digoxin, Furosemide, Metformin, and Rosuvastatin

2016 · Clinical Pharmacology & Therapeutics · 73 citations

https://doi.org/10.1002/cpt.406

Peter Stopfer Thomas Gießmann Kathrin Hohl Anil Kumar Sharma

Effects of Metformin and Furosemide on Rosuvastatin Pharmacokinetics in Healthy Volunteers: Implications for Their Use as Probe Drugs in a Transporter Cocktail

2017 · European Journal of Drug Metabolism and Pharmacokinetics · 30 citations

https://doi.org/10.1007/s13318-017-0427-9

Peter Stopfer Thomas Gießmann Kathrin Hohl Ashish Sharma

Safety, tolerability, pharmacokinetics, and pharmacodynamics of BI 685509, a soluble guanylyl cyclase activator, in healthy volunteers: Results from two randomized controlled trials

2024 · Naunyn-Schmiedeberg s Archives of Pharmacology · 5 citations

https://doi.org/10.1007/s00210-024-03165-w

Diane Wong Friedeborg Seitz Verena C. Bauer Thomas Gießmann

Research topics

topics

Drug Transport and Resistance Mechanisms

Pharmacogenetics and Drug Metabolism

Pharmacological Effects and Toxicity Studies

Thyroid Disorders and Treatments

Gastrointestinal motility and disorders

Chat about Author

Papers

Chat

Click to start Chat